Quick Guide to Recent Changes We’ve Made to G2’s Reports
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
Lab staffing expert shares three key strategies for recruiting and retaining talent during difficult economic times.
Lab industry insiders say they’re confident the Saving Access to Laboratory Services Act (SALSA) will pass in 2023.
While the last few weeks haven’t seen many lab-related enforcement actions, several healthcare companies had to pay big.
G2 Intelligence’s June 13-14 virtual event offers expert advice to help labs navigate today’s economic challenges.
Two recent panel discussions focused on why super-clean orders are important in health care and the challenges that currently prevent them.
Last week’s three key cases included two involving drug testing that was either medically unnecessary, or not provided at all.
While the rule has not yet been approved, if it is, nursing degrees would be considered the equivalent of biological science degrees.
The acquisition of the Johns Hopkins spin out and its liquid biopsy ctDNA test will significantly strengthen Quest’s oncology offerings.
In addition to the usual FCA-related fare, an arrest warrant was issued for a convicted lab co-owner after he failed to show up for prison.
Lucira has fallen on hard times since it secured the first FDA EUA for an at-home COVID-19 test in November 2020.